Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clemastine Treatment in Individuals With Williams Syndrome
NCT06087757Phase 2Active, not recruiting
- Sponsor
- Sheba Medical Center
- Start
- Apr 2024
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clemastine in Williams syndrome, sponsored by Sheba Medical Center. Started Apr 2024; status: active, not recruiting.
02
Drugs
clemastine
03
Conditions
Williams syndrome
Beyond the preview
Go deeper on NCT06087757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06087757.